ANCHORDX
Guangzhou Baseline Medical is committed to building a world-class clinical application of high-throughput sequencing and R & D platform to become the leading global provider of precision medical solutions. The company's core team has more than 20 years of senior industry experience, involved in cancer genomics, genetics and bioinformatics and other fields. Based on its core technical advantages, the Company aims at precision medicine, establishes a cooperative relationship with middle and downs... tream enterprises in the industry, and forms a complete industrial chain from academic research to clinical product transformation. It has also established close cooperation with many large-scale third-party inspection agencies including Illumina, Well-known domestic and foreign hospitals and research institutes to establish cooperative relations, the development of a series of independent intellectual property rights and international competitiveness of clinical testing products for patients, doctors and medical institutions to provide accurate, convenient and comprehensive services.
ANCHORDX
Social Links:
Industry:
Biotechnology Emergency Medicine Pharmaceutical Precision Medicine
Founded:
2015-01-01
Address:
Guangzhou, Guangdong, China
Country:
China
Website Url:
http://www.anchordx.com
Total Employee:
51+
Status:
Active
Contact:
400-930-0052
Email Addresses:
[email protected]
Total Funding:
68 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Content Delivery Network SSL By Default Mobile Non Scaleable Content Nginx Pound Sterling PHP
Similar Organizations
BRIM Biotechnology
BRIM Biotechnology is a pharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Creative Biosciences
Creative Biosciences is a biomedical technology company.
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
Lianchuan Bio
Lianchuan Bio is provider of a genomics and precision medicine platform in China.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Pacylex
Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.
Primo Biotechnology
Primo aims at precision medicine and help the development of radioligand theranostics (RLT).
Vision Medicals
Vision Medicals is a gene technology and precision medicine company.
Current Employees Featured
Founder
Investors List
WuXi AppTec
WuXi AppTec investment in Series C - AnchorDx
OrbiMed
OrbiMed investment in Series C - AnchorDx
6 Dimensions Capital
6 Dimensions Capital investment in Series B - AnchorDx
WuXi AppTec
WuXi AppTec investment in Series B - AnchorDx
Sijia Jianxin Fund
Sijia Jianxin Fund investment in Series B - AnchorDx
KingMed Diagnostics
KingMed Diagnostics investment in Series B - AnchorDx
Marathon Venture Partners
Marathon Venture Partners investment in Series B - AnchorDx
ARCH Venture Partners
ARCH Venture Partners investment in Series B - AnchorDx
Marathon Venture Partners
Marathon Venture Partners investment in Series A - AnchorDx
Northern Light Venture Capital
Northern Light Venture Capital investment in Series A - AnchorDx
Newest Events participated
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-07 | AnchorDx Appoints Dr. Marina Bibikova as Chief Scientific Officer |
Official Site Inspections
http://www.anchordx.com
- Host name: 120.78.190.149
- IP address: 120.78.190.149
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "AnchorDx"
About Us-AnchorDx
AnchorDx, established in Guangzhou International Bio Island in 2015, has set up R&D centers in China and the United States. It is committed to the R&D, production and sales of early cancer screening and diagnosis products using โฆSee details»
AnchorDx - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 400-930-0052 Guangzhou Baseline Medical is committed to building a world-class clinical application of high-throughput sequencing and R & D platform to become the โฆSee details»
Better Diagnostics, Better Life-AnchorDx
AnchorDx has completed series A, A+ and C financing in total of US$83 million; the cooperation of multiple international renowned investment institutions and industry leading enterprises indicates that the high-throughput sequencing โฆSee details»
AnchorDx Company Profile 2024: Valuation, Investors ... - PitchBook
AnchorDx General Information Description. Developer of next-generation sequencing techniques. The company's next-generation sequencing techniques utilizes molecular liquid biopsies which โฆSee details»
AnchorDx - Funding, Financials, Valuation & Investors - Crunchbase
AnchorDx is a precision medicine firm. How much funding has this organization raised over time? ShowSee details»
ๅผ้ข็ฒพๅๅป็๏ผ้ ็ฆๅๅฎถไธๆท-ๅบๅๅป็
ๅบๅๅป็ไบ2015ๅนดๅจๅนฟๅทๅฝ้ ็็ฉๅฒๆ็ซ๏ผๅจไธญๅฝๅ็พๅฝๅ่ฎพ็ซไบ็ ๅไธญๅฟ๏ผ่ดๅไบ้็จๅฝ้ ๅ ่ฟ็็ฒๅบๅ้ซ้้ๆตๅบ่ฟ่ก็็ๆฉ็ญๆฉ่ฏไบงๅ็ ๅใ็ไบงๅ้ๅฎ๏ผๅนถๅฏๆไพ็ธๅบ็ๆฃๆตๆๅกใSee details»
Anchordx, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Oct 24, 2024 Explore Anchordx, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
AnchorDx - Products, Competitors, Financials, Employees, โฆ
AnchorDx focuses on precision medicine in the healthcare sector. The company offers products for early cancer screening and diagnosis, utilizing advanced methylation sequencing โฆSee details»
AnchorDx Company Profile - Office Locations, Competitors ... - Craft
AnchorDx has 5 employees at their 1 location and $68 m in total funding,. See insights on AnchorDx including office locations, competitors, revenue, financials, executives, subsidiaries โฆSee details»
AnchorDx - VentureRadar
" Founded in 2015, AnchorDx develops high-throughput sequencing, also known as Next-generation sequencing technology, which can sequence DNA and RNA much more quickly โฆSee details»
AnchorDx - Contacts, Employees, Board Members, Advisors
Organization. AnchorDx . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. About. AnchorDx has 2 โฆSee details»
AnchorDx Achieves Academic Breakthrough with Deep โฆ
Dec 9, 2021 The organization was founded in 1979 by Turing Award winners Marvin Minsky and John McCarthy. The annual AAAI Conference is the world's top academic conference in the โฆSee details»
AnchorDx Completes USD 40 Million Series C Financing to โฆ
Feb 23, 2021 AnchorDx is a world-leading developer of DNA methylation NGS products, which was founded by world-renowned scientists and investors on 25 August 2015 in Guangzhou, โฆSee details»
AnchorDx, DiaCarta Partner Developing Novel Cancer Screening โฆ
Nov 13, 2023 About AnchorDx Founded in 2015, AnchorDx is a world-leading developer of cancer screening and early detection solutions based on methylation technology. AnchorDx โฆSee details»
AnchorDx, DiaCarta Partner to Advance Cancer Screening Tests
Nov 13, 2023 Guangzhou, China-based AnchorDx's DNA methylation-based bladder cancer early detection test was granted a breakthrough device designation by the US Food and Drug โฆSee details»
Core Advantages-AnchorDx
To deal with the low conversion efficiency of bisulfite treatment, we have developed a single-strand DNA library preparation method, AnchorIRIS®, to reach 30-40% of overall conversion โฆSee details»
AnchorDx Enrolls the First Patient For Its UriFind® Bladder Cancer ...
Nov 23, 2022 About AnchorDx Better Diagnostics, Better Life. Founded in 2015, AnchorDx is a world-leading developer of cancer screening and early detection solutions based on โฆSee details»
AnchorDx enters into a collaboration with the Lung Cancer โฆ
GUANGZHOU, China, July 16, 2020 /PRNewswire/ -- AnchorDx, a leading biotechnology company developing novel NGS-based early cancer detection and disease monitoring tests, โฆSee details»
2020 AACR | AnchorDx Unveiled A New Generation of Methylation ...
Jun 25, 2020 The AnchorDx Aurora test targets six major cancers, including lung, breast and digestive system cancers (colorectum, stomach, esophagus and liver), which accounts for โฆSee details»
2021 ASCO - AnchorDx Unveils Robust Validation Result of Multi โฆ
GUANGZHOU, China, June 21, 2021 /PRNewswire/ -- At this year's American Society of Clinical Oncology (ASCO) Annual Meeting 2021 (June 4-8), AnchorDx, a world-leading developer of โฆSee details»